Australia’s rising obesity burden: can pharmacists help?
This is another epidemic that must be addressed – through active living and nutrition policies.
Breathing change into asthma care
Updated guidelines in the Australian Asthma Handbook were released in September 2025 with SABA-only therapy now considered risky in adults and adolescents.
Chlamydia and gonorrhoea
Chlamydia and gonorrhoea are two of the most prevalent bacterial sexually transmitted infections (STIs) globally.
Balancing the scale: the role of oral anticoagulants in atrial fibrillation
Atrial fibrillation is the most common recurrent arrhythmia worldwide, and can put patients at increased risk of stroke.
From chemist to pharmacist and beyond …
Centenarian and PSA life member JSD ‘Stan’ Mellick OAM, ED, PhC, BA, PhD reflects on a 75-year association with pharmacy.
Should cannabidiol be down-scheduled to S3?
The Therapeutic Goods Administration (TGA) has delivered an interim decision to down-schedule low dose cannabidiol.
